Cost effectiveness of three months of rifapentine and isoniazid for latent tuberculosis in Syrian refugees

BACKGROUND: Latent Tuberculosis infection (LTBI) has a large global burden especially among refugees. We aimed to test the cost effectiveness of weekly rifapentine plus isoniazid for 3 months (3HP) versus nine months of daily isoniazid (INH-9) to treat LTBI in Syrian refugees residing in Turkey. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Ilaiwy, Ghassan, Dowdy, David W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326807/
https://www.ncbi.nlm.nih.gov/pubmed/34368467
http://dx.doi.org/10.1016/j.jctube.2021.100262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326807/
https://www.ncbi.nlm.nih.gov/pubmed/34368467
http://dx.doi.org/10.1016/j.jctube.2021.100262

Ejemplares similares